Sapporo Medical University / 札幌医科大学

University / College


Location: Sapporo, Japan (JP) JP

ISNI: 0000000106910855

ROR: https://ror.org/01h7cca57

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer (2023) Mlecnik B, Lugli A, Bindea G, Marliot F, Bifulco C, Lee JKJ, Zlobec I, et al. Journal article Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study (2022) Casadei-Gardini A, Rimini M, Kudo M, Shimose S, Tada T, Suda G, Goh MJ, et al. Journal article Efficacy of Upadacitinib Dose Escalation in a Phase 3 Long-Term Extension Ulcerative Colitis Study (2022) Panaccione R, Long M, Ran Z, Atreya R, Nakase H, Zhou W, Yao X, et al. Conference contribution Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study (2022) Mlecnik B, Torigoe T, Bindea G, Popivanova B, Xu M, Fujita T, Hazama S, et al. Journal article Clinical performance of Immunoscore (R) in early colon cancer in the Asian population (2020) Galon J, Kawakami Y, Torigoe T, Wang Y, Patel PS, Vora H, Mlecnik B, et al. Conference contribution Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer (2020) Mlecnik B, Bifulco C, Bindea G, Marliot F, Lugli A, Lee JJ, Zlobec I, et al. Journal article A TNM-Immune (TNM-I) classification staging system for predicting survival in colon cancer in a multicenter international SITC study (2020) Mlecnik B, Bifulco C, Marliot F, Lugli A, Nagtegaal I, Hartmann A, Van Den Eynde M, et al. Conference contribution Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients (2019) Galon J, Hermitte F, Mlecnik B, Marliot F, Bifulco C, Lugli A, Nagtegaal I, et al. Conference contribution MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies (2018) Galon J, Mlecnik B, Hermitte F, Marliot F, Bifulco C, Lugli A, Nagtegaal ID, et al. Conference contribution Systematic identification of cancer-specific MHC-binding peptides with RAVEN (2018) Baldauf MC, Gerke JS, Kirschner A, Blaeschke F, Effenberger M, Schober K, Rubio RA, et al. Journal article, Original article